Teva UK Limited Launches Rivastigmine Capsules

Informations

• Publié par: teva-uk-ltd
• Nombre de lectures: 23
• Langue: English

Extrait

Teva UK Limited Launches Rivastigmine

Capsules

PR Newswire

CASTLEFORD, England, June 22, 2012

CASTLEFORD, England

,

June 22, 2012

/PRNewswire/ --

We are pleased to announce the launch of Rivastigmine capsules for generic

prescription.

Rivastigmine is a version of Exelon

®

(Rivastigmine) from Novartis. It is indicated

in the symptomatic treatment of mild to moderately severe Alzheimer's

dementia. And in the symptomatic treatment of mild to moderately severe

dementia in patients with idiopathic Parkinson's disease.

Rivastigmine capsules are available immediately in Teva 360 livery, as follows:

Rivastigmine

Pack size x 28

Strength

1.5mg

3mg

4.5mg

6mg

Brand Price

GBP33.25

GBP33.25

GBP33.25

GBP33.25

Initial Teva Retail Price

GBP18.29

GBP18.29

GBP18.29

GBP18.29

Rivastigmine

Pack size x 56

Strength

1.5mg

3mg

4.5mg

6mg

Brand Price

GBP66.51

GBP66.51

GBP66.51

GBP66.51

Initial Teva Retail Price

GBP36.58

GBP36.58

GBP36.58

GBP36.58

Alzheimer's UK estimates the financial cost of dementia to the UK will be over

£23 billion in 2012

[1]

.

Kim Innes, Commercial Director at Teva said: "We're really pleased to be

making more medicines accessible for more people with the launch of

Rivastigmine capsules. So far this year, we've launched 20 new products,

including ten day-one patent expiries, which is good for Pharmacy because new

products provide opportunities for increasing margins and keeping costs down.

But, more importantly it also means we continue to help save the NHS over

£9bn a year."

New or existing customers can order through a Teva Territory Sales Manager,

their wholesaler, or call

0800 085 8621

For more information, visit http://www.tevauk.com.

Notes to Editors:

About Teva UK Limited

Teva UK Limited is one of the UK's top ten pharmaceutical manufacturers, with

a presence in the generics, branded respiratory and hospitals markets. It has

the widest range of any UK generic pharmaceutical company and markets solid

and liquid dose, injectable and respiratory medicines to healthcare

professionals. The company is part of Teva Pharmaceutical Industries Ltd.

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global

pharmaceutical company, committed to increasing access to high-quality

healthcare by developing, producing and marketing affordable generic drugs as

well as innovative and specialty pharmaceuticals and active pharmaceutical

ingredients. Headquartered in

Israel

, Teva is the world's leading generic drug

maker, with a global product portfolio of more than 1,300 molecules and a

direct presence in about 60 countries. Teva's branded businesses focus on CNS,

oncology, pain, respiratory and women's health therapeutic areas as well as

biologics. Teva currently employs approximately 46,000 people around the

world and reached

$18.3 billion

in net revenues in 2011.

1. Checked on

14 June 2012

-

http://alzheimers.org.uk/site/scripts/documents_info.php?documentID=341

For media enquiries, contact the Teva UK media team on [phone],

or email [e-mail].